BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38493226)

  • 1. The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers.
    Ronchetti D; Traini V; Silvestris I; Fabbiano G; Passamonti F; Bolli N; Taiana E
    Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38493226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NONO and tumorigenesis: More than splicing.
    Feng P; Li L; Deng T; Liu Y; Ling N; Qiu S; Zhang L; Peng B; Xiong W; Cao L; Zhang L; Ye M
    J Cell Mol Med; 2020 Apr; 24(8):4368-4376. PubMed ID: 32168434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
    Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
    Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
    [No Abstract]   [Full Text] [Related]  

  • 4. Paraspeckle subnuclear bodies depend on dynamic heterodimerisation of DBHS RNA-binding proteins via their structured domains.
    Lee PW; Marshall AC; Knott GJ; Kobelke S; Martelotto L; Cho E; McMillan PJ; Lee M; Bond CS; Fox AH
    J Biol Chem; 2022 Nov; 298(11):102563. PubMed ID: 36209820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation.
    Passon DM; Lee M; Rackham O; Stanley WA; Sadowska A; Filipovska A; Fox AH; Bond CS
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4846-50. PubMed ID: 22416126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
    Snijders AP; Hautbergue GM; Bloom A; Williamson JC; Minshull TC; Phillips HL; Mihaylov SR; Gjerde DT; Hornby DP; Wilson SA; Hurd PJ; Dickman MJ
    RNA; 2015 Mar; 21(3):347-59. PubMed ID: 25605962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma.
    Ronchetti D; Favasuli VK; Silvestris I; Todoerti K; Torricelli F; Bolli N; Ciarrocchi A; Taiana E; Neri A
    Discov Oncol; 2022 Nov; 13(1):124. PubMed ID: 36367609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8.
    Iino K; Mitobe Y; Ikeda K; Takayama KI; Suzuki T; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
    Cancer Sci; 2020 Jan; 111(1):148-159. PubMed ID: 31733123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of RNA binding proteins of the
    Takeiwa T; Ikeda K; Horie K; Inoue S
    RNA Biol; 2024 Jan; 21(1):1-17. PubMed ID: 38551131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of NONO is associated with impaired cardiac function and fibrosis in mice.
    Xu X; Jiang H; Lu Y; Zhang M; Cheng C; Xue F; Zhang M; Zhang C; Ni M; Zhang Y
    J Mol Cell Cardiol; 2019 Dec; 137():46-58. PubMed ID: 31634484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of NONO induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma.
    Cheng R; Zhu S; Guo S; Min L; Xing J; Guo Q; Li P; Zhang S
    Oncol Rep; 2018 Jun; 39(6):2575-2583. PubMed ID: 29620226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of SFPQ-NONO heterodimer.
    Schell B; Legrand P; Fribourg S
    Biochimie; 2022 Jul; 198():1-7. PubMed ID: 35245601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
    Chen Y; Xu X; Ding K; Tang T; Cai F; Zhang H; Chen Z; Qi Y; Fu Z; Zhu G; Dou Z; Xu J; Chen G; Wu Q; Ji J; Zhang J
    J Exp Clin Cancer Res; 2024 Feb; 43(1):39. PubMed ID: 38303029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear scaffold protein p54
    Shen M; Zhang R; Jia W; Zhu Z; Zhao X; Zhao L; Huang G; Liu J
    Oncogene; 2021 Jun; 40(24):4167-4183. PubMed ID: 34079086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
    Lu JY; Sewer MB
    Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing Regulator p54
    Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
    Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of dimerization and nucleic acid binding of human DBHS proteins NONO and PSPC1.
    Knott GJ; Chong YS; Passon DM; Liang XH; Deplazes E; Conte MR; Marshall AC; Lee M; Fox AH; Bond CS
    Nucleic Acids Res; 2022 Jan; 50(1):522-535. PubMed ID: 34904671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation.
    Fan XJ; Wang YL; Zhao WW; Bai SM; Ma Y; Yin XK; Feng LL; Feng WX; Wang YN; Liu Q; Hung MC; Wan XB
    Am J Cancer Res; 2021; 11(6):2838-2852. PubMed ID: 34249431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA-Binding Protein NONO Coordinates Hepatic Adaptation to Feeding.
    Benegiamo G; Mure LS; Erikson G; Le HD; Moriggi E; Brown SA; Panda S
    Cell Metab; 2018 Feb; 27(2):404-418.e7. PubMed ID: 29358041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism.
    Laurenzi T; Palazzolo L; Taiana E; Saporiti S; Ben Mariem O; Guerrini U; Neri A; Eberini I
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.